Literature DB >> 11819587

Gastroesophageal reflux and Helicobacter pylori: a review.

F Pace, G Bianchi Porro.   

Abstract

Entities:  

Year:  2000        PMID： 11819587      PMCID： PMC4688741          DOI： 10.3748/wjg.v6.i3.311

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  35 in total

1.  Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.

Authors:  R Eissele; G Brunner; B Simon; E Solcia; R Arnold
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

2.  Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus.

Authors:  M R Quddus; J D Henley; R A Sulaiman; T C Palumbo; D R Gnepp
Journal:  Hum Pathol       Date:  1997-09       Impact factor: 3.466

3.  Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.

Authors:  B E Schenk; E J Kuipers; E C Klinkenberg-Knol; S A Eskes; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

4.  The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.

Authors:  F T Peters; E J Kuipers; S Ganesh; W J Sluiter; E C Klinkenberg-Knol; C B Lamers; J H Kleibeuker
Journal:  Aliment Pharmacol Ther       Date:  1999-07       Impact factor: 8.171

Review 5.  Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle.

Authors:  H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

6.  Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer.

Authors:  T A Wright; M Myskow; A N Kingsnorth
Journal:  Dis Esophagus       Date:  1997-07       Impact factor: 3.429

7.  Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole.

Authors:  E F Verdú; D Armstrong; J P Idström; J Labenz; M Stolte; G Dorta; G Börsch; A L Blum
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.

Authors:  J Labenz; B Tillenburg; U Peitz; J P Idström; E F Verdú; M Stolte; G Börsch; A L Blum
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

9.  Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus.

Authors:  R J Loffeld; B J Ten Tije; J W Arends
Journal:  Am J Gastroenterol       Date:  1992-11       Impact factor: 10.864

10.  Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole.

Authors:  J G Hatlebakk; A Berstad
Journal:  Aliment Pharmacol Ther       Date:  1997-12       Impact factor: 8.171
View more
  3 in total

1.  Polymorphism of flagellin A gene in Helicobacter pylori.

Authors:  W S Ji; J L Hu; J W Qiu; D R Peng; B L Shi; S J Zhou; K C Wu; D M Fan
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Expression of Helicobacter pylori Hsp60 protein and its immunogenicity.

Authors:  Yang Bai; Liang-Ren Li; Ji-De Wang; Ye Chen; Jian-Feng Jin; Zhao-Shan Zhang; Dian-Yuan Zhou; Ya-Li Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Impact of Helicobacter pylori infection on histological changes in non-erosive reflux disease.

Authors:  Anthie Gatopoulou; Konstantinos Mimidis; Alexandra Giatromanolaki; Alexandros Polichronidis; Nikolaos Lirantzopoulos; Efthimios Sivridis; George Minopoulos
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.